Position in NKTR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,599,265
+$2,050,809 QoQ
Shares Held
36,126
+178.5% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Informed Momentum Co LLC holds $117,620,448 across 34 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
49,357 | $9,243,578 | |
| 2 | TVTX |
Travere Therapeutics, Inc.
|
117,987 | $6,702,841 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
26,152 | $6,401,225 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
19,498 | $6,163,122 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
16,227 | $6,031,089 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
24,544 | $5,914,367 | |
| 7 | CYTK |
Cytokinetics Inc
|
68,185 | $5,808,680 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
120,928 | $5,688,453 |
All Filings in NKTR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,599,265 | 36,126 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $548,456 | 12,972 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,450,092 | 78,209 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $624,191 | 24,156 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||